C07K 5/02 containing at least one abnormal peptide link
Introduced: January 1985
Last revised: January 2006
Full Title
Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof > containing at least one abnormal peptide link
Classification Context
- Section:
- CHEMISTRY; METALLURGY
- Class:
- ORGANIC CHEMISTRY
- Subclass:
- PEPTIDES
Filing statistics
IPC C07K 5/02 belongs to the parent subclass C07K, which recorded 434,419 patent applications worldwide between 2013 and 2023. Annual filings grew from 29,263 in 2013 to 39,574 in 2023 (+35%), peaking at 47,586 applications in 2021. The most active applicants in class C07 are CHINESE ACADEMY OF SCIENCES (12,697 applications), ROCHE (11,347 applications) and SINOPEC (CHINA PETROCHEMICAL CORPORATION) (11,024 applications).
Source: EPO PATSTAT, worldwide filings
5 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C07K 5/023 in which at least a beta-amino acid is involved
- C07K 5/027 in which at least a gamma-amino acid is involved, e.g. statine
- C07K 5/03 in which at least a delta-amino acid is involved, e.g. isosteres
- C07K 5/033 in which at least an epsilon- or zeta-amino acid is involved
- C07K 5/037 the abnormal link being formed by the side chain of an alpha-amino acid, e.g. gamma-Glu, epsilon-Lys, glutathione
Top Applicants
Top 10 applicants by patent filingsfor class C07, 2013–2023, worldwide · Source: EPO PATSTAT
- CHINESE ACADEMY OF SCIENCES 12,697
- ROCHE CH 11,347
- SINOPEC (CHINA PETROCHEMICAL CORPORATION) 11,024
- NOVARTIS CH 9,356
- BASF (BADISCHE ANILIN & SODA FABRIK) DE 8,531
- BRISTOL-MYERS SQUIBB COMPANY US 7,320
- LG CHEM KR 7,245
- REGENERON PHARMACEUTICALS US 6,816
- HARVARD UNIVERSITY US 6,190
- GENENTECH US 5,922